Gaps in allergen immunotherapy administration and SCIT dose-adjustment schedules: need for prospective data

Many abrupt adjustments in the delivery of medical care became necessary due to the unexpected emergence of the COVID-19 pandemic in early 2020. In order to ensure social distancing and the concomitant requirements for personal protective equipment, practitioners have had to make a myriad of adjustments in order to continue providing subcutaneous allergen immunotherapy (SCIT). In many practices SCIT was stopped or administration intervals have been increased, while other practices have transitioned some patients to the sublingual administration route.(1)
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Perspective Source Type: research